Zhou et al. also generated a CPZ loaded mouse ATF-HSA (mATF-HSA:CPZ) that achieved an enhanced murine tumour targeting ability and an enhanced PDT efficacy compared with hATF-HSA:CPZ [176]. The gene discussed is CPZ; the disease is neoplasm.